BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹-1.84 Cr | ₹27 Cr | ₹22 Cr | ₹23 Cr | ₹7.76 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAL PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2023 | ₹-1.84 Cr |
Mar2022 | ₹27 Cr |
Mar2021 | ₹22 Cr |
Mar2020 | ₹23 Cr |
Mar2019 | ₹7.76 Cr |
How is Cash Flow from Operating Activities of BAL PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-1.84 Cr | Negative | |
Mar2022 | ₹27 Cr | 19.97 | |
Mar2021 | ₹22 Cr | -3.91 | |
Mar2020 | ₹23 Cr | 199.60 | |
Mar2019 | ₹7.76 Cr | - |
Compare Cash Flow from Operating Activities of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹157.7 Cr | -3% | -1.1% | 17.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -3% |
-1.1% |
17.9% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses